Cocrystal Pharma Inc

NASDAQ:COCP  
0.71
-0.05 (-6.81%)
Earnings Announcements

Cocrystal Pharma Reports 4 Cents Q3 Loss Per Share

Published: 11/15/2021 13:24 GMT
Cocrystal Pharma Inc (COCP) - Cocrystal Pharma Reports Third Quarter Financial Results and Provides an Update on Development Programs and Milestones.
Q3 Loss per Share $0.04.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.04

Next Quarter Revenue Guidance is expected to be $0.5 Million
Next Quarter EPS Guidance is expected to be -$0.04

More details on our Analysts Page.